Depression and Anxiety in Patients with Chronic Respiratory Diseases

Transcription

1 Depression and Anxiety in Patients with Chronic Respiratory Diseases

2 Amir Sharafkhaneh Abebaw Mengistu Yohannes Nicola Alexander Hanania Mark E. Kunik Editors Depression and Anxiety in Patients with Chronic Respiratory Diseases 123

3 Editors Amir Sharafkhaneh, MD, PhD Professor of Medicine Department of Medicine Baylor College of Medicine Staff Physician Michael E. DeBakey VA Medical Center Houston, TX, USA Abebaw Mengistu Yohannes, PhD, MSc Department of Health Professions Manchester Metropolitan University Manchester, UK Nicola Alexander Hanania, MD, MS, FCCP Baylor College of Medicine Houston, TX, USA Mark E. Kunik, MD, MPH Baylor College of Medicine Houston, TX, USA ISBN ISBN (ebook) DOI / Library of Congress Control Number: Springer Science+Business Media LLC 2017 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Printed on acid-free paper This Springer imprint is published by Springer Nature The registered company is Springer Science+Business Media LLC The registered company address is: 233 Spring Street, New York, NY 10013, U.S.A.

4 Preface As populations age, the prevalence of chronic respiratory conditions increases steadily. Further, recent advances in various health-related fields have been extending human longevity. Undoubtedly, chronic medical conditions, with no exception for chronic respiratory conditions, affect quality of life negatively and result in various psychiatric conditions including depression and anxiety. Thus, as the prevalence of chronic medical conditions increases, the prevalence of associated psychiatric conditions increases too. In this book, we aim at evaluating various chronic respiratory conditions associated with psychiatric comorbidities and explore the management options available. Chapters 1 8 are dedicated to psychiatric conditions in various respiratory problems. In Chap. 1, Drs. Rose and Sharafkhaneh provide a general overview of respiratory conditions and how they promote depression and other psychiatric comorbidities. In Chap. 2, Drs. Dooley and Kunik review depression and anxiety across various age groups. In Chap. 3, Drs. Yohannes and Willgross discuss various tools that are used to assess depression and anxiety. Drs. Majid and Nadim, in Chap. 4, focus on chronic obstructive pulmonary disease (COPD) and depression. In Chap. 6, Drs. Malatack and Barto explore depression and anxiety in patients with cystic fibrosis. Dr. Sista and colleagues, in Chap. 7, focus on psychiatric conditions in end-stage lung disease and lung transplantation. Finally, Drs. Hasmi and Khawaja explore psychiatric conditions in sleep disorders. The second part of this book focuses on management strategies including pharmacological and non-pharmacological interventions to treat depression and anxiety in patients with chronic respiratory conditions. Chapter 10, by Drs. Hynninen and Nordus, brings our attention to non-pharmacological intervention while Chap. 11, by Drs. Yohannes and Leroi, focuses on medication for depression and anxiety. At last, Drs. Ponti and Braun explore end-of-life issues in patients with advanced respiratory conditions. We hope that this collection of chapters from practitioners and researchers with different medical backgrounds can v

5 vi Preface provide a solid basis for clinicians who take care of patients with chronic and advanced lung diseases. We would like to thank the staff at Springer for their tremendous help to make this project successful. Houston, TX, USA Amir Sharafkhaneh, MD, PhD

6 Contents 1 Overview of Psychological Considerations in the Management of Patients with Chronic Respiratory Conditions... 1 Mary Rose and Amir Sharafkhaneh 2 Depression and Anxiety Across the Age Spectrum Erin Dooley and Mark E. Kunik 3 Diagnostic Tools for Anxiety and Depression Abebaw Mengistu Yohannes and Thomas George Willgoss 4 Anxiety and Depression in COPD Patients Hashir Majid and Tania Nadeem 5 Depression and Anxiety in Adult Patients with Asthma Abebaw Mengistu Yohannes and Nicola Alexander Hanania 6 Depression and Anxiety in the Cystic Fibrosis Population James Joseph Malatack and Tara Lynn Barto 7 End-Stage Lung Disease and Lung Transplantation Kapil Rangavajhala, Kathryn Blanchard and Ramachandra R. Sista 8 Sleep-Disordered Breathing and Mental Illness Ali Madeeh Hashmi and Imran Shuja Khawaja 9 The Impact of Comorbidities in Patients with Chronic Respiratory Diseases Abebaw Mengistu Yohannes 10 Non-pharmacological Interventions to Manage Depression and Anxiety Associated with Chronic Respiratory Diseases: Cognitive Behavioral Therapy and Others Minna J. Hynninen and Inger Hilde Nordhus vii

7 viii Contents 11 Pharmacological Therapy and Anxiolytics in Patients with Respiratory Diseases Abebaw Mengistu Yohannes and Iracema Leroi 12 Palliative and End-of-Life Issues in Patients with Advanced Respiratory Diseases Glencora Sharfman and Ursula K. Braun Index

8 Contributors Tara Lynn Barto, MD Division of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA Kathryn Blanchard, LCSW Division of Pulmonary Medicine, Phoenix, AZ, USA Ursula K. Braun, MD, MPH Michael E. DeBakey VA Medical Center and Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Houston, TX, USA; Baylor College of Medicine, Houston, TX, USA Erin Dooley, MD Department of Psychiatry, University of Virginia, Charlottesville, VA, USA Nicola Alexander Hanania, MD, MS, FCCP Department of Pulmonary and Critical Care, Baylor College of Medicine, Houston, TX, USA Ali Madeeh Hashmi, MBBS, MD King Edward Medical University/Mayo Hospital, Lahore, Pakistan Minna J. Hynninen, PhD NKS Olaviken, Hospital for Old Age Psychiatry, Erdal, Norway; Department of Clinical Psychology, University of Bergen, Bergen, Norway Imran Shuja Khawaja, MD Center for Sleep Medicine, VA North Texas Health Care System, Dallas, TX, USA; Psychiatry and Neurology, UT Southwestern Medical Center, Dallas, TX, USA Mark E. Kunik, MD, MPH Baylor College of Medicine, Houston, TX, USA Iracema Leroi, MD The University of Manchester, Manchester, UK Hashir Majid, MBBS, FCCP Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University, Karachi, Pakistan James Joseph Malatack, MD Division of Hospital Medicine, Medstar Georgetown University Hospital, Washington, DC, USA ix

9 x Contributors Tania Nadeem, MBBS, MD Department of Psychiatry, Aga Khan University, Karachi, Pakistan Inger Hilde Nordhus, PhD Faculty of Psychology, Department of Clinical Psychology, University of Bergen, Bergen, Norway; Faculty of Medicine, Department of Behavioural Sciences in Medicine, University of Oslo, Oslo, Norway Kapil Rangavajhala, MD Division of Pulmonary Medicine, Phoenix, AZ, USA Mary Rose, PsyD TIRR Memorial Hermann, Houston, TX, USA Amir Sharafkhaneh, MD, PhD Department of Medicine, Baylor College of Medicine, Michael E. DeBakey VA Medical Center, Houston, TX, USA Glencora Sharfman, MD Baylor College of Medicine, Houston, TX, USA Ramachandra R. Sista, MD Division of Pulmonary Medicine, Phoenix, AZ, USA Thomas George Willgoss, PhD, MSc Department of Health Professions, Manchester Metropolitan University, Manchester, UK Abebaw Mengistu Yohannes, PhD, MSc Department of Health Professions, Manchester Metropolitan University, Manchester, UK